NCT07324785 Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis
| NCT ID | NCT07324785 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northern Jiangsu People's Hospital |
| Condition | Diabetic Gastroparesis |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-01-07 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective observational study. The study will explore the correlation between advanced glycation end products and gastric motility disorder in diabetic gastroparesis（DGP) through the collection of blood and gastric tissue samples and relevant data of patients with DGP and control group patients without diabetes history and gastroparesis symptoms.
Eligibility Criteria
Inclusion Criteria for diabetes gastroparesis group: * Meet the diagnostic criteria for diabetes * Presence of symptoms (see assessment of Gastroparesis Cardinal Symptom Index) * Age range from 18 to 75 years old * Voluntarily participate and sign an informed consent form Inclusion Criteria for control group: * No history of diabetes * No symptoms (see assessment of Gastroparesis Cardinal Symptom Index) * Age range from 18 to 75 years old * Voluntarily participate and sign an informed consent form Exclusion Criteria for diabetes gastroparesis group and control group: * Currently taking prokinetic drugs, anticholinergic drugs, and dopamine drugs that may affect gastric motility * Has a history of gastrointestinal surgery * Pregnant or preparing to conceive * There are neurological disorders such as Parkinson's disease that affect gastrointestinal function * Outlet obstruction caused by organic lesions in the pylorus
Contact & Investigator
Ying Zhu, Doctor's degree
PRINCIPAL INVESTIGATOR
Northern Jiangsu People's Hospital
Frequently Asked Questions
Who can join the NCT07324785 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Diabetic Gastroparesis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07324785 currently recruiting?
Yes, NCT07324785 is actively recruiting participants. Contact the research team at bujingzhuying@126.com for enrollment information.
Where is the NCT07324785 trial being conducted?
This trial is being conducted at Yangzhou, China.
Who is sponsoring the NCT07324785 clinical trial?
NCT07324785 is sponsored by Northern Jiangsu People's Hospital. The principal investigator is Ying Zhu, Doctor's degree at Northern Jiangsu People's Hospital. The trial plans to enroll 50 participants.